Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F4GZ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,911
Award facts
- Contract value 100% obligated
- $15,911.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,911.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cimzia 2X200 mg/ml syringe kits. This non-competitive delivery order, issued on February 3, 2026, with an ultimate completion date of February 4, 2026, represents a task order against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical, which extends through December 2026 and serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities across multiple therapeutic domains. The Cimzia order supports the broader Defense Health Agency and military treatment facility requirements for immunosuppressive therapy, with the compressed fulfillment timeline indicating urgent medical supply needs within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26F4GZ6?
SPE2DR26F4GZ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F4GZ6 worth?
The government has obligated $15,911 on SPE2DR26F4GZ6.
Is contract SPE2DR26F4GZ6 an order under another contract?
Yes. SPE2DR26F4GZ6 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GZ6 competed?
The extent of competition for SPE2DR26F4GZ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award